期刊文献+

食管黏膜不同病变阶段患者血清Ep-CAM水平及临床意义 被引量:3

The Clinical Significance and Level of Ep-CAM Eexpression in the Sera of the Patients with Different Pathological Changes of Esophageal Mucosa
下载PDF
导出
摘要 目的探讨上皮细胞黏附分子(Ep-CAM)在食管癌、食管黏膜不典型增生患者血清中的表达水平及意义。方法应用酶联免疫(ELISA)的方法,检测正常对照人群、食管黏膜不典型增生、食管癌患者血清中Ep-CAM的表达水平。结果p-CAM在正常对照、食管黏膜不典型增生、食管癌患者血清中的水平呈梯度升高,P<0.01;中、重度不典型增生患者血清中的Ep-CAM表达水平明显高于轻度组,P=0.036;Ep-CAM表达水平与食管癌的转移明显相关,P<0.001,且在手术前后表达水平明显降低,P<0.001。结论患者血清中Ep-CAM表达水平的变化出现在食管黏膜病变的早期阶段,其表达与食管癌的发生发展明显相关,可作为疾病监测的特异指标。 Objective To investigate the clinical significance and level of epithelial cellular adhesion molecule (Ep- CAM) expression in the sera of the patients with esophageal cancer or esophageal atypical hyperplasia. Methods We examined Ep-CAM expression by enzymelinked immunosorbent assay (ELISA). Results The Ep-CAM level in serum was significantly different in the normal, esophageal cancer and esophageal atypical hyperplasia groups, P 〈 0.01. The Ep-CAM level of moderate dysplasia and hyperplasia groups was higher than the mild dysplasia,P = 0.036. The serum Ep-CAM level was associated with metastasis of esophageal cancer, The serum Ep-CAM level was significantly reduced after operation, P 〈 0. 001. Conclusion The enhanced expression of Ep-CAM is an early step in the malignant transformation of epithelium, and can be used as a marker for diagnostic purpose.
出处 《实用癌症杂志》 2007年第4期338-340,共3页 The Practical Journal of Cancer
基金 河北省科技厅指导计划项目(编号062761197)
关键词 食管癌 不典型增生 上皮细胞黏附分子 酶联免疫法 Esophageal cancer Atypical hyperplasia Epithelial cellular adhesion molecule Euzymelinked immunosorbent assay
  • 相关文献

参考文献5

  • 1Litvinov SV,Van Driel W,Van Rhijn CM,et al.Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation[J].Am J Pathol,1996,148(3):865.
  • 2Songun I,Litvinov SV,Van de Velde CJ,et al.Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer[J].Br J Cancer,2005,92(9):1767.
  • 3Nikolas H S,Annika S,Peter S,et al.Ep-CAM expression in squamous cell carcinoma of the esophagus:a potential therapeutic target and prognostic marker[J].BMC Cancer,2006,23 (6):165.
  • 4Winter MJ,Nagelkerken B,Mertens AEE,et al.Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak[J].Exp Cell Res,2003,285(1):50.
  • 5Gutzmer R,Li W,Sutterwala S,et al.,A tumour-associated glycoprotein that blocks MHC class Ⅱ-dependent antigen presentation by dendritic cells[J].J Immunol,2004,173(2):1023.

同被引文献15

  • 1孙昕,陈振东,龚浩.617例肿瘤患者血清12种肿瘤标志物检测[J].安徽医科大学学报,2004,39(5):396-398. 被引量:4
  • 2宋玉,刘晓燕,张萍,吴强,徐振山,宋礼华.抗人结肠癌相关抗原单克隆抗体的制备及初步研究[J].中国免疫学杂志,2006,22(4):353-355. 被引量:3
  • 3陈创,陈利琴,杨国梁,李雁.肿瘤标志物在结直肠癌诊断和监测中的价值[J].武汉大学学报(医学版),2007,28(2):207-211. 被引量:11
  • 4柳晓燕,姚晓玲,宋玉,刘晓燕,张萍,徐振山,宋礼华.结肠癌相关抗原的制备及其临床意义[J].细胞与分子免疫学杂志,2007,23(4):335-337. 被引量:4
  • 5Munz M, Kieu C, Mack B, et al. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation[ J]. Oncogene, 2004,23 ( 34 ) : 5748 - 58.
  • 6Went P, Vassei M, Bubendorf L, et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate, and lung cancers[J]. Br J Cancer,2006,94 (1) : 128 -35.
  • 7Amann M, Brischwein K, Lutterbuese P , et al. Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3 [ J]. Cancer Res,2008, 68 (1) : 143 -51.
  • 8Litvinov S V, Balzar M, Winter M J, et al. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interaction mediated by classic cadherins[J]. J Cell Biol, 1997,139 ( 5 ) : 1337 - 48.
  • 9Songun I,Litvinov SV,van de Velde C J, et al. Loss of Ep-CAM (CO17- 1A) expression predicts survival in patients with gastric cancer. Br J Cancer, 2005,92 : 1767-1772.
  • 10Calabrese G, Crescenzi C, Morizio E, et al. Assignment of TACSTD1 ( alias TROP1, M4Sl ) to human chromosome 2p21 and refinement of mapping of TACSTD2 ( alias TROP2, M1 S1 ) to human chromosome 1 p32 by in situ hybridization. Cytogenet Cell Genet,2001,92:164-165.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部